- 05.02.2019, 14:18:38
- /
- OTE0005
EANS-DD: Marinomed Biotech AG / Notification concerning transactions by persons performing managerial responsibilities pursuant to article 19 Market Abuse Regulation (MAR) - ATTACHMENT
--------------------------------------------------------------------------------
Directors' Dealings-Announcement pursuant to artikle 19 MAR transmitted by
euro adhoc with the aim of a Europe-wide distribution. The issuer is
responsible for the content of this announcement.
--------------------------------------------------------------------------------
personal data:
responsible party:
name: Ute Lassnig (natural person)
--------------------------------------------------------------------------------
reason:
reason: responsible party is a person with managerial responsibilities
function: Member of an administrative or supervisory board
--------------------------------------------------------------------------------
issuer information:
name: Marinomed Biotech AG
Legal Entity Identifier (LEI): 529900GN3B1EN80XF405
--------------------------------------------------------------------------------
information about deal:
ISIN: ATMARINOMED6
description of the financial instrument: Stock
type: acquisition
date: 30.01.2019; UTC+01:00
market: WIENER BOERSE AG, XWBO
currency: Euro
price volume
75 570
total volume: 570
total price: 42750
average price: 75
--------------------------------------------------------------------------------
end of announcement euro adhoc
--------------------------------------------------------------------------------
Attachments with Announcement:
----------------------------------------------
http://resources.euroadhoc.com/documents/10197870/4/10261271/1/DD_Lassnig_Laureo_2019_01_31.pdf
issuer: Marinomed Biotech AG
Veterinärplatz 1
A-1210 Wien
phone: 0043250774460
FAX: 0043250774493
mail: office@marinomed.com
WWW: www.marinomed.com
ISIN: AT0000A1WD52, ATMARINOMED6
indexes:
stockmarkets: Wien
language: English
ORIGINAL APA-OTS TEXT - THE INFORMATION CONTAINED IN THIS PRESS RELEASE IS SUBJECT TO THE EXCLUSIVE RESPONSIBILITY OF THE ISSUER | EAE